Pro-inflammatory cytokine release in rectal surgery: comparison between laparoscopic and open surgical techniques.

The objective of the present study was to investigate whether laparoscopic rectal surgery causes a less pronounced release of pro-inflammatory cytokines as compared to open surgical technique. Twenty-four consecutive patients undergoing rectal surgery due to cancer disease were included in a prospective and randomized trial. The patients were randomized to laparoscopic (n = 12) or open surgery (n = 12). Blood was sampled at five occasions; after induction of anesthesia before start of surgery, at 180, 360 min and 24 h after start of surgery and the last sample was taken in the late post-operative period 3-5 days after surgery. The levels of interleukin (IL)-1α, IL-6, IL-8, IL-10, tumor necrosis factor-α, C-reactive protein (CRP), white blood cells, intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 were analyzed using multiplex sandwich enzyme-linked immunosorbent assay. There was a release of both pro- and anti-inflammatory cytokines during colorectal surgery. The release of IL-6, IL-10 and CRP was significantly lower in the laparoscopic group. Rectal surgery causes release of both pro- and anti-inflammatory cytokines. The inflammatory response is lower in laparoscopic rectal surgery as compared to conventional open surgery. Less tissue trauma in laparoscopic rectal surgery and/or less peri-operative bleeding in the laparoscopic cases leads to a lower degree of inflammatory response.

Release of PMN elastase, TGF-beta1 and neopterin during blood storage; unfiltered versus filtered blood.

Release of inflammatory mediators from blood cells during prestorage leukocyte filtration may result in recipient immune suppression. To investigate the effects of prestorage leukocyte filtration on the quality of blood components, twenty-four blood units were collected from healthy donors and randomised into 3 groups. Eight units were stored as whole blood, eight units were separated into plasma, red blood cells (RBC) and buffy coat and eight units were collected and filtered through the ASAHI RZ 2000 leukocyte filter and separated into plasma and RBC. The units were stored for 35 days. Samples were collected weekly for analyses of polymorphonuclear elastase (PMN elastase), transforming growth factor-beta1 (TGF-beta1) and neopterin. PMN elastase and neopterin increased during storage of whole blood and RBC. From the beginning and throughout storage, PMN elastase was increased in filtered plasma as compared with unfiltered plasma. Filtration per se did not influence the neopterin concentration in plasma or RBC. TGF-beta1 increased in plasma and RBC during storage. In filtered plasma, an elevation of the TGF-beta1 concentration was observed from the start of storage. The TGF-beta1 levels were higher in filtered plasma compared with unfiltered plasma. Prestorage leukocyte filtration increased the release of PMN elastase and TGF-beta1 in plasma and RBC.

Activation of the complement system by different autologous transfusion devices: an in vitro study.

BACKGROUND: The aim of the present investigation was to study whether autologous transfusion devices activate the complement system and whether complement-activated blood is more vulnerable to further activation during processing. STUDY DESIGN AND METHODS: Forty-eight blood units were randomized to be processed by one of three different salvage systems: Group 1 underwent whole blood filtration (hemofiltration) (n=16); Group 2 underwent continuous processing, saline washing, and centrifugation (CATS, Fresenius AG ) (n=16); and Group 3 underwent saline washing and centrifugation (Cell-Saver, Haemonetics Corp.) (n=16). Eight blood units for each system were activated with cobra venom factor (CVF) at a concentration of 0.2 U per mL whole blood before processing. C activation was studied by determinations of C4d, Bb, C3a, and SC5b-9. Samples were drawn from whole blood, processed blood, and the waste bags. RESULTS: The concentrations of Bb, C3a, and SC5b-9 in whole blood after activation with CVF were significantly elevated compared to blood that was not activated (p < 0.01). Processed blood from hemofiltration contained significantly higher levels of complement-split products than techniques that use washing and centrifugation. The concentrations of SC5b-9 in blood processed by hemofiltration were higher in the experiments with CVF activation (p < 0.05). CONCLUSION: The tested autologous transfusion systems did not themselves activate the complement system, and complement-activated blood was not more vulnerable to further activation during processing. A blood-salvaging technique that used washing and centrifugation reduced elevated concentrations of complement-split products, whereas hemofiltration did not.

Autologous blood transfusion in radical hysterectomy with and without erythropoietin therapy.

OBJECTIVE: To investigate whether preoperative treatment with erythropoietin facilitates the collection of a sufficient amount of autologous blood in a short period of time. METHODS: Forty-one women scheduled for radical hysterectomy were randomized to preoperative autologous blood donation with or without preoperative recombinant human erythropoietin therapy. All patients were scheduled to deposit three units of blood within 2 weeks before surgery. Hemoglobin, erythrocyte volume fraction, blood cells, iron status, and hemolysis were analyzed before and after surgery. RESULTS: Hemoglobin levels decreased continuously in both groups after the first autologous donation until day 1 postoperatively. With erythropoietin therapy, the erythrocyte volume fraction and hemoglobin levels were significantly higher during precollection and day 1 after surgery. Preoperatively, the drop was 12 g/L less in the erythropoietin-treated group. The additional use of erythropoietin therapy reduced the inability of patients to predeposit blood from 17.8% to 3.4%. CONCLUSION: Most women can predeposit three units of whole blood in only 2 weeks without obtaining severe anemia. By treating women with erythropoietin, one out of seven can be prevented from a hemoglobin level below the 100 g/L limit for donation.

Airway oximetry improves monitoring of dopamine effects in pediatric cardiac patients.

OBJECTIVE: Simple, preferably noninvasive measurements of cardiac output are useful in pediatric patients receiving inotropic support. Oxygen saturation in pulmonary artery (Svo(2)) gives information about oxygen delivery and demand. Many inotropic drugs influence oxygen consumption. When effects on Svo(2) are studied, after a change in inotropic drug dosage, a change in oxygen consumption needs to be considered to accurately estimate the change in cardiac output. The aim of this investigation was to study whether information on inspired to end-tidal oxygen concentration difference (Fi-eto(2)) in addition to Svo(2) would improve estimation of changes in cardiac output. DESIGN: Prospective observational study of Fi-eto(2), Svo(2), and oxygen saturation from central vein (Scvco(2)) for measurements of circulatory and metabolic effects of changes in dopamine dosage. SETTING: Intensive care unit in a children's hospital. PATIENTS: Twenty patients (age 4 days to 98 months) were studied after cardiac surgery. INTERVENTIONS: Dopamine was administered in doses of 5, 10, 0, and 5 microg x kg(-1) x min(-1), 20 mins on each level. MEASUREMENTS AND MAIN RESULTS: Cardiac output, measured with thermodilution, oxygen saturation from systemic artery (Sao(2)), Svo(2), and Scvco(2) were measured at 15 mins on each dopamine dose. Oxygen consumption was calculated by using the Fick equation. Fi-eto(2) was measured continuously with a paramagnetic oxygen analyzer. Both cardiac output and oxygen consumption were affected by changes in dopamine dosage. Relative changes in cardiac output were poorly correlated to the change in 1/Sa-vo(2) (r(2) =.54). Using Fi-eto(2) improved correlation between changes in cardiac output and changes in Fi-eto(2)/Sa-vo(2) (r(2) =.72). When Svo(2) was replaced by Scvco(2), the correlation between changes in cardiac output and changes in Fi-eto(2)/Sa-cvco(2) was only slightly altered (r(2) =.69). CONCLUSIONS: Dopamine affects oxygen consumption as well as cardiac output. The accuracy of Svo(2)-based estimations of changes in cardiac output after dopamine is enhanced if changes in Fi-eto(2) are also considered. The more easily achievable Scvco(2) gave equivalent information as Svo(2).